Jfl Life Sciences Limited Share Price & Stock Analysis

JFL Life Sciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers beta lactam dry powder injections, beta lactam tablets and capsules in solid oral dosage form, oral rehydration solutions, and general tablets and capsules. It also exports its products to Africa, the Middle East, and CIS countries through merchant exporters. JFL Life Sciences Limited was incorporated in 2010 and is headquartered in Ahmedabad, India.

Key Metrics

Current Price	₹10.60
Market Cap	₹0 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products
P/E Ratio	5.5
Beta (1Y)	0.17
Dividend Yield	0.00%

Business Segments

1. Pharmaceuticals Manufacturing-100%

Peer Companies

• Sanofi Consumer Healthcare India Ltd
• ASTONEA LABS LIMITED
• Bacil Pharma Ltd.
• Goldline Pharmaceutical Limite
• Venmax Drugs And Pharmaceuticals Ltd
• RUBICON RESEARCH LIMITED
• Sunrest Lifescience Limited
• Valiant Laboratories Limited

Frequently Asked Questions

What is the current share price of Jfl Life Sciences Limited?

Jfl Life Sciences Limited is trading at ₹10.60, with a market capitalisation of ₹0 Cr.

Which sector does Jfl Life Sciences Limited belong to?

Jfl Life Sciences Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products).

What are the key financial ratios of Jfl Life Sciences Limited?

Jfl Life Sciences Limited has a P/E of 5.5.